Skip to content

PERIodontal Disease, Microbiota and Miscarriage

Status Report on Periodontal Status and Oral Microbiota Women Who Have Suffered Repeated Miscarriages: a Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06576622
Acronym
PERI2M
Enrollment
30
Registered
2024-08-29
Start date
2024-11-29
Completion date
2026-12-30
Last updated
2026-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Miscarriage, Parodontitis

Keywords

REPEATED MISCARRIAGES, Porphyromonas gingivalis, SALIVA, BIOLOGICAL SAMPLES, subgingival plaque

Brief summary

Cross-sectional non-interventional observational pilot study recruiting women whom had repeated miscarriages (= at least 3 miscarriages).The information will be collected during a routine maintenance, complete oral clinical and radiological examination (assessment carious, periodontal, mucosal and functional), which is part of the routine assessment in the service of odontology from Toulouse University Hospital. Saliva and subgingival plaque samples, classically carried out in routine dental surgery as part of the health check-up oral, will be used to carry out bacterial assays.

Detailed description

Cross-sectional non-interventional observational pilot study recruiting women whom had repeated miscarriages (= at least 3 miscarriages).The information will be collected during a routine maintenance, complete oral clinical and radiological examination (assessment carious, periodontal, mucosal and functional), which is part of the routine assessment in the service of odontology from Toulouse University Hospital. As part of the health check-up oral, Will be taken: * Salivary samples by sputum (1 per patient). The patient will retain her saliva for 1 minute in the mouth and it will be collected in a sterile bottle (approximately 5 ml). * Samples of subgingival plaque in the periodontal sulcus (assessed during periodontal probing) using sterile paper points (minimum 3 and maximum 10 per patient) inserted for 30 seconds into the periodontal sulcus then put in a tube sterile. The plate collection is done by capillary action on the paper tip, a very small quantity is thus taken. A collection of the history and disease risk factors will then be carried out. periodontal problems (stress level assessed using the visual analogue scale, history personal and family periodontal diseases, oral hygiene habits, etc.) by a routine care interview, the clinical examination (visual examination and recording of oral and periodontal) and radiological examination.

Interventions

OTHERbiological sampling

As part of the health check-up oral, Will be taken: * Salivary samples by sputum. * Samples of subgingival plaque in the periodontal sulcus * A collection of the history and disease risk factors will then be carried out. * periodontal problems by a routine care interview, the clinical examination and radiological examination.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* women whom had repeated miscarriages * at least 6 natural teeth

Exclusion criteria

* under antibiotic prebiotic or probiotics treatment one month prior to the study * with high infection risk (HIV,...)

Design outcomes

Primary

MeasureTime frameDescription
average quantity of Porphyromonas gingivalisAT INCLUSION = T0estimate the average quantity of Porphyromonas gingivalis (Pg) in saliva patients who have had recurrent miscarriages (3 consecutive miscarriages \< 14 weeks of amenorrhea)

Secondary

MeasureTime frameDescription
microbiological compositionAT INCLUSION = T0microbiological composition of the saliva in women having had repeated miscarriages : Salivary samples by sputum (1 per patient). The patient will retain her saliva for 1 minute in the mouth and it will be collected in a sterile bottle (approximately 5 ml).

Countries

France

Contacts

CONTACTalexia VINEL, md
vinel.a@chu-toulouse.fr+33 5 61 32 25 09
CONTACTstephanie brayer
Brayer.Stephanie@iuct-oncopole.fr+33 5 61 32 25 09

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 13, 2026